We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
(Site Profile/Docket Number 075)
Location: Waterbury, Connecticut
Also Known As: American Brass Co., Fabric Metal Goods Plant and West Tube Mill, Anamet, Inc., Anaconda Co.
The Special Exposure Cohort (SEC) is a unique category of employees established by the Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Anaconda Co.
The Anaconda Co. discussion papers listed below are working documents prepared by NIOSH or its contractor for use in discussions with the Advisory Board on Radiation and Worker Health or its Working Groups or Subcommittees. Draft, preliminary, interim, and white paper documents are not final NIOSH or Advisory Board (or their technical support and review contractors) positions unless specifically marked as such. These documents represent preliminary positions taken on technical issues prepared by NIOSH or its contractor.
The discussion papers have been reviewed to identify and redact any information that is protected by the Privacy Act 5 USC §552a and have been cleared for distribution.
SC&A Presentation: Review of One Advisory Board-Selected Case Reworked for the Evaluation of Anaconda Technical Basis Document Revisions (DCAS-PER-065, Subtask 4) [309 KB (17 pages)]
Presentation at the November 3, 2021, Teleconference Meeting of the Subcommittee for Procedure Reviews
SC&A Draft: Review of NIOSH’s Program Evaluation Report DCAS-PER-065, “Anaconda” [638 KB (23 pages)]
Contract No. 211-2014-58081
SCA-TR-2017-PR004, Revision 0
June 15, 2017
How to Submit Comments
Comments on Anaconda Co. Documents can be submitted to the NIOSH Docket Officer electronically by email at email@example.com or printed comments can be mailed to:
NIOSH Docket Office
Robert A. Taft Laboratories, MS-C34
1090 Tusculum Avenue
Cincinnati, OH 45226
Please include the Site Profile/Docket Number (075) on all comments.
At this time, no comments have been submitted.